ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, abnormal localization and increased expression of ERα36 occur in IM-nonresponder CML stem/progenitor cells and IM-resistant cell lines, including BCR-ABL-T315I mutant cells.